| SC 13G/A | 2024-02-14 | VIKING GLOBAL INVESTORS LP | Viking Therapeutics, Inc. | 5,145,112 | 5.1% | EDGAR |
| SC 13G | 2024-02-13 | VANGUARD GROUP INC | Viking Therapeutics, Inc. | 5,381,904 | 5.4% | EDGAR |
| SC 13G/A | 2024-02-09 | FMR LLC | Viking Therapeutics, Inc. | 15,004,340 | 15.0% | EDGAR |
| SC 13G | 2024-01-26 | BlackRock Inc. | Viking Therapeutics, Inc. | 7,605,867 | 7.6% | EDGAR |
| SC 13G/A | 2024-01-24 | STATE STREET CORP | Viking Therapeutics, Inc. | - | 5.7% | EDGAR |
| SC 13G/A | 2024-01-12 | MILLENNIUM MANAGEMENT LLC | Viking Therapeutics, Inc. | 403,556 | 0.4% | EDGAR |
| SC 13G | 2023-11-02 | VIKING GLOBAL INVESTORS LP | Viking Therapeutics, Inc. | 5,858,532 | 5.9% | EDGAR |
| SC 13G | 2023-04-10 | FMR LLC | Viking Therapeutics, Inc. | 10,922,747 | 11.4% | EDGAR |
| SC 13D/A | 2023-03-30 | LIGAND PHARMACEUTICALS INC | Viking Therapeutics, Inc. | 3,616,077 | 4.6% | EDGAR |
| SC 13G/A | 2023-02-14 | ArrowMark Colorado Holdings LLC | Viking Therapeutics, Inc. | 15,931 | 0.0% | EDGAR |
| SC 13D/A | 2023-02-09 | LIGAND PHARMACEUTICALS INC | Viking Therapeutics, Inc. | 6,065,080 | 7.9% | EDGAR |
| SC 13G/A | 2023-02-03 | STATE STREET CORP | Viking Therapeutics, Inc. | - | 0.3% | EDGAR |
| SC 13G | 2023-01-03 | MILLENNIUM MANAGEMENT LLC | Viking Therapeutics, Inc. | 4,829,200 | 6.3% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | Viking Therapeutics, Inc. | 1,427,221 | 1.8% | EDGAR |
| SC 13G/A | 2022-02-14 | STATE STREET CORP | Viking Therapeutics, Inc. | - | 5.3% | EDGAR |
| SC 13G/A | 2022-02-14 | ArrowMark Colorado Holdings LLC | Viking Therapeutics, Inc. | 7,060,803 | 9.0% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | Viking Therapeutics, Inc. | 5,119,490 | 6.5% | EDGAR |
| SC 13G/A | 2021-02-16 | ArrowMark Colorado Holdings LLC | Viking Therapeutics, Inc. | 8,507,790 | 11.7% | EDGAR |
| SC 13G | 2021-02-11 | STATE STREET CORP | Viking Therapeutics, Inc. | - | 7.0% | EDGAR |
| SC 13G/A | 2021-02-01 | BlackRock Inc. | Viking Therapeutics, Inc. | 5,316,337 | 7.3% | EDGAR |